Replies to post #199607 on Avid Bioservices Inc (CDMO)

[InternetForumUser]

Interesting..information

REVEL Phase 3--- Start to FDA Approval 4 Years
Started December 2010
Patients over 1,200
Number of Sites 231
FDA Approval December 2014

SUNRISE Phase 3:
Started December 2013
Patients almost 600
Number of sites so far 151

If SUNRISE maintains the same timeline as the REVEL Trial.. December 2017 for FDA Approval... Wow that would be a long time...

[Protector]

Bad luck for Eli Lilly. The improved 15% on Docetaxel will already be beaten by Docetaxel+bavituximab in less then 24 months.

If I was Eli or Lilly I'd ASAP start a clinical trial with Ramucirumab+Bavituximab and hope that the 15% improvement compared to Doocetaxel+Bavituximab will still hold.

Alternatively sabotaging our PIII may also be a solution if they don't get caught.

It's 1 AM so now I have part two of my evening to take care of.